Welcome to CDC Stacks | Draft CDC guideline for prescribing opioids for chronic pain, 2016 : summary of constituent comments and CDC response - 36832 | Stephen B. Thacker CDC Library collection
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Draft CDC guideline for prescribing opioids for chronic pain, 2016 : summary of constituent comments and CDC response
  • Published Date:
    12/20/15
  • Language:
    English
Filetype[PDF - 486.17 KB]


Details:
  • Corporate Authors:
    National Center for Injury Prevention and Control (U.S.). Division of Unintentional Injury Prevention.
  • Description:
    CDC hosted two constituent engagement webinars on September 16 and 17, 2015 for comment on the Draft CDC Guideline for Prescribing Opioids for Chronic Pain, 2016. Approximately 765 people participated in the live webinars and over 1200 verbal and written comments were received during the webinars or via email until September 18, 2015. Constituents were able to hear about the scope, audience, and development process, and review the draft recommendation statements on the webinars. A summary of the problem, intended purpose and use, clinical practices addressed, and guideline development process was posted on the CDC Injury Center website at http://www.cdc.gov/drugoverdose/prescribing/guideline.html. Comments were received from physicians and other health care providers, pharmacists, professional organizations, pain advocacy organizations, state and local health departments, and patients.

    CDC subject matter experts carefully reviewed each comment individually and considered modifications to the guideline document in response. Comments were categorized into themes which are presented below, with example comments highlighting each theme. Comments were diverse and have been organized by recommendation statement and consistent themes that emerged. This summary captures the larger constructive themes of the constituent’s written comments, and is not inclusive of all the individual comments received. Similarly, this summary captures the more substantive edits made to the guideline in response to constituent engagement and is not inclusive of all the edits made. The summary reflects edits made after all constituent comments were reviewed and feedback from CDC clearance reviewers on the revision was received. CDC thanks participating constituents for providing comments that will improve the quality, credibility, and implementability of the recommendations for opioid prescribing.

    http://www.regulations.gov/#!documentDetail;D=CDC-2015-0112-0005

    Publication date from documnet properites.

    CDC-2015-0112-0005

  • Supporting Files:
    No Additional Files